ArisGlobal Hosts 2020 Safety Advisory Board Meeting, Bringing Together Industry Leaders to Align on the Future of Pharmacovigilance
On May 19th and 20th, pharmacovigilance leaders from across the ...
On May 19th and 20th, pharmacovigilance leaders from across the ...
If you are on the front lines of regulatory information ...
On May 14, 2020, ArisGlobal hosted a webinar titled Regulatory ...
Christina Johnson, Associate Director Product Management Regulatory at ArisGlobal will be presenting at the Global Pharmaceutical Regulatory Affairs Summit Digital Week, on June 25th, 2020.
The ArisGlobal marketing department spent time with Clint Wolfe, Chief Human Resources Officer. They discussed changes at ArisGlobal, working from home, how different areas of the globe are handling COVID-19 differently, and more.
The DIA 2020 Annual Meeting Is Now Virtual. ArisGlobal will be front and center with presentations covering both Safety and Clinical perspectives in Life Sciences process management.
The Evolving Role of CTMS in Risk Management takes a broad look at the challenges facing clinical trial management, how the clinical domain is changing, and how the industry can better respond.
A versatile Clinical Trial Management Solution, LifeSphere® CTMS10 contains great functionality and five key benefits, addressing a variety of challenges in the clinical product lifecycle.
Managing and Mastering Pharmacovigilance covers how LifeSphere Multivigilance 10 benefits small to medium-sized businesses by utilizing industry-standard practices and proper management processes.
A key offering in ArisGlobal’s LifeSphere platform, LifeSphere Reporter empowers field reps, provides fields teams and approved users with secure access, and easily integrates with LSMV10 and other systems.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved